Previous 10 | Next 10 |
2023-11-22 11:16:40 ET Penny stocks refer to shares of small or micro-cap companies that trade for less than $5 per share. What cheap stocks lack in size and stability, they can potentially make up for in rapid price changes and explosive short-term gains. For risk-tolerant investors, a...
BRISBANE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class i therapeutics that combine both targeted and immune-mediated mechanisms, today announced that management will participate in a fireside c...
2023-11-09 13:24:45 ET More on Tempest Therapeutics Tempest Therapeutics continues wild ride as stock rallies 85% (update) Tempest stock falls 61% after rocketing 4,000% in prior session Seeking Alpha’s Quant Rating on Tempest Therapeutics Historical e...
2023-11-09 12:48:14 ET Gainers: Intelligent Bio Solutions ( INBS ) +149% . Pineapple Financial ( PAPL ) +87% . Ramaco Resources ( METC ) +34% . Tempest Therapeutics ( TPST ) +30% . Fitell Corp ( FTEL ) +32% . Honest Company (...
2023-11-09 12:21:26 ET DENVER, Colo., Nov. 9, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Intelligent Bio Solutions Inc (NASDAQ: INBS), PubMatic Inc (NASDAQ: PUBM), Tempest Therapeutics Inc (NA...
2023-11-09 10:02:09 ET DENVER, Colo., Nov. 9, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Intelligent Bio Solutions Inc (NASDAQ: INBS), Marathon Digital Holdings, Inc. (NASDAQ: MARA), Tempest Therapeu...
2023-11-09 10:00:37 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
Tempest Therapeutics Inc. (TPST) is expected to report $-0.55 for Q3 2023
2023-11-08 18:04:35 ET More on Tempest Therapeutics Tempest Therapeutics continues wild ride as stock rallies 85% (update) Tempest stock falls 61% after rocketing 4,000% in prior session Seeking Alpha’s Quant Rating on Tempest Therapeutics Historical e...
TPST-1120 demonstrates superiority compared to standard of care across multiple study endpoints in randomized first-line HCC study New capital strengthens balance sheet and extends cash runway into 2025 BRISBANE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc....
News, Short Squeeze, Breakout and More Instantly...
Tempest Therapeutics Inc. Company Name:
TPST Stock Symbol:
NASDAQ Market:
Tempest Therapeutics Inc. Website:
A look at the top 10 most actives in the United States SMX (Security Matters) Public Limited Company (SMX) rose 43.0% to $0.1702 on volume of 99,421,591 shares NVIDIA Corporation (NVDA) rose 3.5% to $140.3486 on volume of 71,277,917 shares MGO Global Inc. (MGOL) rose 222.9% to $1.48 on vo...
21 months median OS in amezalpat arm vs. 15 in control arm 50% (20/40) of patients on amezalpat arm remain in survival follow up 0.65 hazard ratio, maintained since 0.59 observed in primary analysis 10 months earlier Early and persistent separation of survival curves ...
BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer, today announced the company plans to report new data from the global ran...